A new test is available for the nervous necrosis virus - a serious disease affecting more than 35 species of fish worldwide. The new PCR method was first achieved through research and development funded by the Australian Research Council at the University of Sydney.

Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes. [ + ]

Strategic partnership will offer best-in-class support and efficient delivery of Agilent Columns and Supplies products. [ + ]

Protein in king cobra venom could lead to development of new therapeutics or molecular probes. [ + ]

CSL, ResMed, Primary Health Care [ + ]

Researchers from Australia and the US find that blood cells are derived from a number of stem cell subtypes. [ + ]

The sight of brown seaweed is not one that would normally have people seeing dollar signs, but for Hobart-based Marinova, its solvent-free technique for extracting the coveted element fucoidan from an introduced species of sea-flora in Tasmania has made it one of Australia’s most promising up and coming biotechs. [ + ]

The regulation of in vitro diagnostics in Australia will undergo significant change as pre-market regulatory approval and inclusion on the Australian Register of Therapeutic Goods is required for IVD devices under the new regulatory scheme, which comes into force on 1 July 2010.

Applications open today for over $150,000 in prizes and fellowships. [ + ]

$20 million state-of-the-art manufacturing facility acquired for $3.85 million. [ + ]

Final results of phase Ia trial of BNC210 announced demonstrating safety and efficacy. [ + ]

Preliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox. [ + ]

A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system. [ + ]

Solagran and BioProspect to develop commercialisation plan for animal health and nutrition products. [ + ]

A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost ‘lab-on-chip’ devices capable of detecting diseases such as kidney failure and diabetes.